BELGRADE, Mont.–(BUSINESS WIRE)–Lattice Biologics Ltd. Ltd. (TSX-V: LBL) (OTCBB: LBLTF) (“Lattice Biologics” or the “Company”) announces it has begun enrolling patients in its Phase 1 clinical trial to address safety and efficacy of its novel stem cell...
ENGLEWOOD CLIFFS, N.J., March 17, 2020 /PRNewswire/ — Enzychem Lifesciences (KOSDAQ: 183490) today announced that it is advancing a domestic clinical trial of EC-18, a new coronavirus treatment candidate, in South Korea. The company has also been in...
CAMBRIDGE, Mass., March 17, 2020 (GLOBE NEWSWIRE) — Surface Oncology (Nasdaq: SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment, today announced that it has initiated a Phase 1/1b...
− Rapid development of research program on investigational Prostate Specific Membrane Antigen-targeted radiohybrid PET imaging agent since company’s 2018 acquisition − BURLINGTON, Mass. & OXFORD, England–(BUSINESS WIRE)–Blue Earth Diagnostics, a Bracco...
Applied Genetic Technologies Corporation has completed enrollment in all dose groups for adult patients with achromatopsia in its phase 1/2 clinical programs, according to a press release. The company is evaluating the safety and efficacy of rAAV2tYF-PR1.7-hCNGA3 in...
Email
Text